代表性论文: 1. Shi C-J#, Pang F-X#, ... Zhang J-F*. 5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1/SLC7A11-mediated ferroptosis. Drug resistance updates. 2025, 78:101181.(中科院一区top,IF:21.7) 2. Shi C-J, Lv M-Y, ... Zhang J-F*: Linc-ROR drive adriamycin resistance by targeting AP-2α/Wnt/β-catenin axis in hepatocellular carcinoma. Cell biology and toxicology 2022, 39(4):1735-1752. 3. Shi C-J, Li S-Y, ... Zhang J-F*: Icariside II suppressed tumorigenesis by epigenetically regulating the circβ-catenin-Wnt/β-catenin axis in colorectal cancer. Bioorganic chemistry 2022, 124:105800. 4. Shi C-J, Xue Z-H,... Zhang J-F*: LncRNA-NEF suppressed oxaliplatin resistance and epithelial-mesenchymal transition in colorectal cancer through epigenetically inactivating MEK/ERK signaling. Cancer gene therapy 2023, 30(6):855-865.( 5. Deng L-Q#, Shi C-J# (Co-first author), ... Zhang J-F*: EIF4A3-negatively driven circular RNA β-catenin (circβ-catenin) promotes colorectal cancer progression via miR-197-3p/CTNND1 regulatory axis. British Journal of Cancer 2024, 130(9):1517-1528. 6. Zeng W-Q#, Shi C-J# (Co-first author), ... Zhang J-F*: LncRNA HOTTIP facilitated tumor growth via stimulating the hnRNPA2B1/ DKK1/Wnt/β-catenin regulatory axis in hepatocellular carcinoma. Genes & Diseases 2024, 11(4). 7. Li S-Y#, Shi C-J# (Co-first author), ... Zhang J-F*: Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer. Journal of Pharmacy and Pharmacology 2023, 75(1):129-138. 8. Deng L-Q#, Li S-Y#, ... Shi C-J*, Zhang J-F*: LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/β-catenin regulatory axis. PloS one 2024, 19(11):e0312417. |